Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Trianz Announces Strategic Growth Capital Investment by Capital Square Partners




SANTA CLARA, Calif., Feb. 21, 2024 /PRNewswire/ — Digital transformation software and services firm Trianz crossed a significant milestone in its journey in the form of a major growth equity investment from Capital Square Partners (CSP), based out of Singapore. Financial terms of the private transaction were not disclosed.

In 2020, Trianz concluded from a global digital transformation study that companies worldwide would face three major barriers in their digital evolution: ever-shrinking competitive windows to transform, hard-to-find digital-ready talent, and financial uncertainties. Thus began a journey of its own transformation, with Trianz disrupting its value proposition and business model from pure-play services to an ‘IP Led’ model. With a vision to deliver the fastest time to value, lowest human dependence, and highest ROI, Trianz built hyper-automated platforms in data and analytics, AI, cloud, and the digital workplace. The company’s relentless pursuit of a new model for transformation has resulted in pivotal milestones, beginning with the acquisition of some of its analytics IP by Amazon in late 2021, and the launch of cutting-edge, zero-code, and SaaS platforms in employee experience, cloud, and data transformations, which are now hosted on AWS.

The company’s flagship platforms—Concierto.Cloud (Migrate, Manage, and Maximize the multi-hybrid cloud); Extrica.AI (Data to AI); and Pulse (Digital Workplace)—deliver industry-leading transformations measured in speed, lower manual efforts, AI, and ROI. Trianz-developed IP is in use by thousands of AWS customers, and its cloud and data/AI platforms see great momentum in partnership with cloud providers. These digital transformation platforms are expected to power over 50% of the company’s new revenues moving forward.

“The impact of a company’s failure to transform on time is enormous on all its stakeholders—customers, partners, employees, leadership, and shareholders. Our ‘Digital Platforms Led’ model accelerates the reinvention of a company’s digital evolution and enables new value propositions which automatically propel it forward,” said Sri Manchala, CEO of Trianz. “Our ‘IP-Led’ model relies on zero-code, SaaS platforms to revolutionize the cloud, data, and employee journeys for companies from global to emerging enterprises across industries. These being hosted on AWS with Extrica.AI now certified and listed on the AWS Marketplace signifies the robustness of our platforms. And undoubtedly, customer success from this new approach gives us enormous pride, satisfaction, and motivation to do more.”

The transformative journey of Trianz itself over the past few years has been remarkable. Trianz thought differently during an unprecedented pandemic and global uncertainties and executed relentlessly. Rajeev Srivastava and Mukesh Sharda, Managing Partners of CSP, jointly said, “We are excited and proud to join forces with Trianz as it shapes a new model for digital transformations for companies worldwide.”

“We have turned a vision we outlined in 2021 into a reality today. This financial partnership with CSP comes at a time when private equity investments into tech-enabled services have shrunk significantly over the past two years. It is a testimony of the success we are delivering to customers and a result of the efforts of Trianz leaders and associates and guidance from our board,” said Sri. “We consummated this partnership with CSP based on the efforts they made to understand the Trianz business, customers, our paradigm shift, and their commitment towards creating an environment that fosters innovation and rapid scaling. Even as we celebrate this success, we recognize the responsibility that comes with it. Trianz will continue pushing boundaries in becoming a leader in digital transformations, delivering value, and setting new benchmarks in the industry,” added Sri.

About Trianz

Founded in California and with an organization of over 2,000 associates across the United States and India, Trianz accelerates the digital evolution of companies from strategy through execution and sustenance. Based on a vision outlined in his book, ‘Crossing the Digital Faultline: 10 Rules of Highly Successful Leaders,’ and an interview with Bloomberg Quint, Sri and the leadership team at Trianz have created a unique, multi-disciplinary, and IP-Led model which enables client transitions to new value propositions, digitalized processes, and great stakeholder experiences utilizing analytics, digital, cloud, infrastructure, and cybersecurity technologies.

Trianz is a Premier Partner of AWS, and its portfolio of technologies and services has been rated #1 for business impact by a Fortune 1000 client base for five years in a row. Trianz has been ranked as one of the best Consulting Firms by Forbes and has been certified as a Great Place to Work for three years in a row. To learn more about Trianz, email [email protected] or visit

Sri Manchala’s interview with Bloomberg can be viewed on Partner | Crossing The Digital Faultline & Leading Towards Transformative Success – YouTube . More information about Crossing the Digital Faultline can be found at Crossing the Digital Faultline | Trianz.

About Capital Square Partners

Founded in 2014 in Singapore, CSP is a private equity firm investing in cross-border technology and business services across Southeast Asia and India. As a sector-focused fund manager with $1.5 billion under management, CSP is one of the largest dedicated technology and technology-enabled business services private equity fund managers in Asia. Over the past decade, the team has invested, created, and exited a number of leading companies in the technology services sector, including Minacs, Indecomm, GAVS Technologies and Accion Labs. CSP holds a Capital Markets Services (CMS) License from the Monetary Authority of Singapore. 

About the Transaction

The investment transaction with Capital Square Partners was led entirely by the corporate development team at Trianz. Legal advice was provided by Menon Associates (India) and Greenberg Traurig (London, UK).

Trianz Media Team
[email protected] 


Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading

Latest news